The purpose of this study is to develop a four-dimensional (4D) intensitymodulated radiation therapy (IMRT) treatment-planning method by modifying and applying a dynamic multileaf collimator (DMLC) motion-tracking algorithm. The 4D radiotherapy treatment scenario investigated is to obtain a 4D treatment plan based on a 4D computed tomography (CT) planning scan and to have the delivery flexible enough to account for changes in tumor position during treatment delivery. For each of 4D CT planning scans from 12 lung cancer patients, a reference phase plan was created; with its MLC leaf positions and three-dimensional (3D) tumor motion, the DMLC motiontracking algorithm generated MLC leaf sequences for the plans of other respiratory phases. Then, a deformable dose-summed 4D plan was created by merging the leaf sequences of individual phase plans. Individual phase plans, as well as the deformable dose-summed 4D plan, are similar for each patient, indicating that this method is dosimetrically robust to the variations of fractional time spent in respiratory phases on a given 4D CT planning scan. The 4D IMRT treatment-planning method utilizing the DMLC motiontracking algorithm explicitly accounts for 3D tumor motion and thus hysteresis and nonlinear motion, and is deliverable on a linear accelerator.
Introduction
Effective management of intrafraction tumor motion has been one of the outstanding issues in modern radiotherapy, especially for the treatment of thoracic and abdominal tumors. Fourdimensional (4D) radiotherapy to incorporate tumor motion strives to minimize the effect of temporal anatomic changes during irradiation (Keall et al 2006) . From an implementation 3822 Y Suh et al standpoint, 4D radiotherapy consists of three tasks: (1) characterizing anatomic motion, (2) creating a treatment plan that accounts for this motion and (3) delivering this treatment plan to the moving anatomy. The first task has been greatly facilitated through the increased use of 4D computed tomography (CT) that provides accurate anatomic motion information. The third task has been investigated and/or clinically implemented by breath-hold or respiratory-gating techniques, or tumor tracking using a dynamic multileaf collimator (DMLC) technique or a robotic couch (Keall et al 2006) ; repositioning the radiation beam to track the moving tumor using DMLC is shown to be a promising method to deliver a 4D radiotherapy treatment (Webb 2006a) . However, creating DMLC leaf sequences to generate a treatment plan that accounts for moving anatomy continues to be a challenge.
Despite its benefit of target dose conformality and normal tissue sparing, intensitymodulated radiation therapy (IMRT) is known to be more susceptible to tumor motion compared with conventional treatment techniques. This is especially the case with an IMRT treatment delivered by a DMLC technique (Bortfeld 2006 , Webb 2006b ). In addition, a constraint on 4D IMRT treatment planning, which is not found in three-dimensional (3D) IMRT cases, is that leaf sequences need to be specifically designed such that the maximum leaf dynamics (velocity and acceleration/deceleration) are rarely exceeded when tracking anatomic motion with an MLC. This mechanical leaf motion constraint adds additional complexity in IMRT treatment planning on 4D CT data sets.
There have been studies on a 4D IMRT treatment-planning optimization and its delivery using a DMLC technique. Trofimov et al compared different approaches of a 4D IMRT optimization sorted by increasing complexity of delivery, and showed that tumor tracking was better than other techniques (Trofimov et al 2005) . They provided a good framework to formulate 4D IMRT treatment-planning optimization problems. However, they did not investigate the robustness of the optimization methods with respect to the delivery methods, thus their study did not create leaf sequences nor include mechanical limitations of a treatment machine, such as MLC leaf motion constraints. Webb et al have developed motioncompensated DMLC techniques to deliver an IMRT treatment. They first proposed a method to account for one-dimensional (1D) rigid body translation, which was based on a modification of the DMLC IMRT technique whereby MLC leaves were arranged to change according to patient breathing (Webb 2005) . They then implemented a strategy to minimize the geometric mismatch between MLC leaf and anatomic locations in one dimension and two dimensions, to find the optimal leaf trajectories, including the maximum leaf velocity constraint Binnie 2006, McClelland et al 2007) . They also investigated a modified DMLC delivery technique for tumor tracking by using a leaf synchronization technique (McQuaid and Webb 2006) . Their motion model was constructed from a patient 4D CT scan, but their strategy was not a full 4D optimization, and they did not demonstrate implementation with a cohort of patients. Papiez et al have developed algorithms for optimized DMLC IMRT delivery for mobile and deforming targets. They demonstrated DMLC leaf sequencing for the target motion in real time and when a priori motion information was available in one dimension, but as of yet not for three dimensions (Papiez 2003 , 2004 . Recently, they applied a real-time DMLC control algorithm for IMRT treatment delivery to targets moving two dimensionally in a beam's eye view (BEV), using a leaf-pair shifting technique (McMahon et al 2008 , Rangaraj et al 2008 . However, their investigations focused on real-time delivery of an IMRT treatment, and thus they did not look at how to create treatment plans for DMLC IMRT. Zhang et al incorporated the respiratory target motion and deformation into a treatmentplanning optimization for helical tomotherapy delivery (Zhang et al 2004 (Zhang et al , 2007 . They showed breathing-correlated delivery of radiation for periodic and reproducible breathing patterns, but Figure 1 . Comparison of the creation of a four-dimensional treatment plan using one-dimensional (1D) translation of multileaf collimator (MLC) leaves from the reference phase (solid red) to a given phase (dashed red) (left) with that using the DMLC motion-tracking algorithm to move MLC leaves to track three-dimensional (3D) tumor motion (right). Only the motion along the MLC leaf travel direction, T 1D , is accounted for on the left; whereas 3D tumor motion, T 3D , is accounted for on the right side.
only for one lung case. Schlaefer et al investigated an approach to consider the relative motion of organs during treatment planning for robotic radiosurgery (Schlaefer et al 2005) . However, their study was restricted to a phantom case. Alasti et al suggested a 4D-weighted MLC position as a function of breathing phase and weighting factor (Alasti et al 2006) . Their 4D-weighted MLC field was based on the MLC position for the static field combined with the dynamic MLC position for the 4D dynamic field, which allowed MLC leaves to follow a moving tumor. However, they did not consider the mechanical constraints of an MLC, and their study was phantom based. Tewatia et al proposed procedures of treatment planning for a breathing-synchronized delivery technique and its delivery (Tewatia et al 2006) . The motion was directly overlaid to the DMLC leaf position, and violations of the mechanical limitations of the hardware were to be avoided at a treatment-planning stage. However, the motion was incorporated into treatment planning after a plan optimization by superimposing target displacement on the leaf positions, which was not optimal leaf sequencing for 4D treatment planning. This study was also phantom based. To date, no other groups have reported techniques that develop leaf sequences as a function of respiratory phase. Therefore, an optimal 4D IMRT treatment-planning method that includes MLC leaf motion constraints and is robust to the variations of fractional time spent in respiratory phases within a given 4D CT planning scan has yet to be developed.
In our previous study, a deliverable 4D IMRT treatment-planning method, which accounted for tumor motion in only one dimension, was proposed (Suh et al 2008b) . A treatment plan for each of the respiratory phases was created by shifting leaf positions of the reference phase plan to the given phase (from solid red to dashed red apertures on the left side of figure 1) along the MLC leaf travel direction. The study showed that accounting for 1D tumor translation was not only practical, but also provided a reasonable approximation. In this work, we describe a methodology that accounts for more complex, 3D tumor motion (see the right side of figure 1 ). This method utilizes an algorithm developed for real-time DMLC motion tracking in an offline manner in order to create 4D IMRT treatment plans. Such a plan explicitly accounts for 3D tumor motion and consequently hysteresis and nonlinear motion (Seppenwoolde et al 2002 , Suh et al 2008a , and it is deliverable on a linear accelerator.
Therefore, the aim of this study is to develop a 4D IMRT treatment-planning method by modifying and applying a DMLC motion-tracking algorithm.
Materials and methods

Treatment scenario
Three-dimensional IMRT aims to create a treatment plan from one CT image, resulting in MLC leaf sequences as a function of monitor units (MU), L (MU). Four-dimensional IMRT, in which modulating the radiation beam to temporally changing anatomy is explicitly included, aims to create a treatment plan on a CT image set of multiple respiratory phases, resulting in leaf sequences as a function of MU and respiratory phase (θ ), L (MU, θ ). Thus, a 4D radiotherapy treatment scenario investigated is to obtain a 4D treatment plan from a 4D CT planning scan and to have delivery flexible enough to account for changes in tumor positions, tumor drift and/or breathing patterns during treatment delivery.
A DMLC motion-tracking algorithm
A DMLC motion-tracking algorithm dynamically tracks moving targets in three dimensions using real-time target location data from an independent position-monitoring system to account for tumor motion during treatment . This algorithm was designed to (a) read initial MLC leaf positions as a function of MU from an MLC leaf sequence derived from a treatment plan, (b) dynamically calculate MLC leaf positions to account for target position changes using real-time 3D target location data from a position-monitoring system, (c) generate new MLC leaf positions as a function of MU and 3D target location by modifying the initial leaf positions in (a) with the calculated leaf positions in (b) and (d) send the generated MLC leaf sequence to a treatment machine to reposition the beam in real time. Further details for this algorithm are described previously . For 4D treatment planning, the DMLC motion-tracking algorithm was modified to include the respiratory phase as an additional parameter and to be used in an offline mode.
4D IMRT treatment planning
The 4D CT image sets used in this study are from 12 lung cancer patients acquired as a part of an institutional review board-approved study (protocol 00-202) at the University of Texas M D Anderson Cancer Center. Table 1 shows the volume and the centroid motion range of patients' gross tumor volume (GTV). A commercially available planning system (Pinnacle version 7.9, Philips Medical Systems, Milpitas, CA) was used for contouring, planning and an IMRT optimization. Using the manually segmented contours on the end-inhale phase of the 4D CT scans and large deformation diffeomorphic image registration (Christensen et al 1997 , Foskey et al 2005 , contours on the other respiratory phases were automatically generated. The clinical target volume enclosed the GTV with an isotropic 8 mm margin, and then a 5 mm margin was added isotropically to create the planning target volume (PTV). For IMRT treatment planning, the prescribed dose was 74 Gy, and beam arrangements were six coplanar, non-opposed, predominantly anterior-posterior fields. Further details for the 4D CT data set, patient characteristics, contouring, planning and an IMRT optimization are described elsewhere (Weiss et al 2007a , 2007b , Suh et al 2008b .
The DMLC motion-tracking algorithm requires two inputs: an initial MLC leaf sequence and real-time 3D target location and phase information. The input MLC leaf sequence was derived from an IMRT treatment plan that was created on the reference phase 4D CT image. From a delivery perspective, real-time target location and phase information are necessary to reposition the beam in real time; for planning purposes, however, 3D offsets of the tumor centroid position for each phase relative to that for the reference phase were used instead. Figure 2 shows a flow diagram of using the same algorithm for both planning and delivery of 4D radiotherapy treatment.
The steps to create a 4D IMRT treatment plan using the DMLC motion-tracking algorithm for each patient are as follows:
(a) For an IMRT treatment plan on the reference phase CT image, an appropriate beam angle arrangement was determined according to the tumor locations. From the tumor centroid position for each respiratory phase, which was quantified from the 4D CT image set, a major axis of tumor motion in each BEV was automatically determined using a leastsquares fit (Suh et al 2008b) . Then, the collimator was rotated to align the MLC leaf travel direction parallel to the major axis of tumor motion. Overall mean of the collimator angles calculated was 88
• , ranging from 10 • to 170
• (12 reference plans with 6 beam angles each). This collimator rotation was performed because of the known decrease in delivery efficiency for the motion perpendicular to the MLC leaf travel direction . As shown by Sawant et al, efficiency of IMRT delivery for the motion perpendicular to the MLC leaf travel direction is significantly lower than that for the motion parallel to the MLC leaf travel direction. For each beam, 3D offsets of the tumor centroid position for each phase i relative to that for the reference phase were calculated as the motion parallel to the major axis, the motion perpendicular to the major axis and the motion along the beam direction, T i (x, y, z|θ i ) (table 1). With the rotated collimator, an appropriate IMRT treatment plan was created on the reference phase 4D CT image (an end-exhale phase was used as the most stable phase during respiration (Seppenwoolde et al 2002) ), where an initial MLC leaf sequence, L (MU|θ ref ), was then derived. (b) With the MLC leaf positions from the initial leaf sequence and the 3D tumor centroid position offsets, the DMLC motion-tracking algorithm generated a set of MLC leaf sequences for each phase of the 4D CT scan, L i (MU|θ i ), which then was used to create IMRT treatment plans for individual respiratory phases. (c) The leaf sequences of individual phase plans were merged to create a leaf sequence for a 4D plan, L 4D (MU, θ ). Using a deformable dose summation (Christensen et al 1997 , Keall et al 2004 , Zhang et al 2004 , Foskey et al 2005 , the resultant doses from all individual phase plans were accumulated on an end-inhale CT image, and a deformable dose-summed 4D plan was created. A 4D dose distribution is given by
where i is a respiratory phase index from 1 to the maximum number of phases, P (P = 10 in this study), λ i is fractional time spent per phase, which in this study was assumed to be the same for all the phases, and D i is a dose of a treatment plan for a given phase. D i was computed on the given phase CT image, I i , on the basis of leaf sequences as a function of MU and θ i , L i (MU, θ i ), and then deformed to the reference phase CT image used for a dose summation, I ref , by a displacement vector field, u(θ i ), computed using deformable image registration. Once the MLC leaf sequence for a 4D plan merging individual phase plans (on the bottom left in figure 2 ) was created, it was used as an initial leaf sequence on the delivery side as in figure 2. The MU and real-time 3D target position and phase, T ( x, y, z|θ), were determined from a treatment machine and a patient position-monitoring system, respectively. The DMLC motion-tracking algorithm software interpolated the initial leaf sequence, L 4D (MU, θ ), using both MU and θ to obtain a new leaf sequence, L , and then modified L using ( x, y, z) to obtain the final leaf sequence, L , that accounted for 3D target motion. The L then was sent to the treatment machine and delivered. The feasibility of delivery of such 4D plans using this method was experimentally validated in a separate work .
It is important to note that it is possible to use the reference phase plan and track the tumor without creating either individual phase plans or a 4D plan. However, the reason we generated individual phase plans was that we wanted to have a plan that was the best estimate of the dose delivered to the patient, which was a 4D plan merging all individual phase plans. Possibly there is relative motion between the target and surrounding normal tissues from phase to phase (Weiss et al 2007b) that could result in different dose distributions for individual phase plans from those for the reference plan; then a 4D plan also would be different from the reference plan. As shown in our previous study (Suh et al 2008c) , a 4D plan was different from the plans for any single phases, at least slightly, and for some patients with bigger target motion or, more importantly, more relative motion between the target and organs, the reference plan was quite different from a 4D plan and also from individual phase plans. Our treatment-planning method was developed especially for this type of patients. Therefore, a 4D plan was generated instead of using the reference plan. This 4D plan gives us an estimate of the 4D dose distribution for the patient.
To evaluate the treatment plans generated, the composite objective values (COVs) and dose-volume evaluation metrics derived from the dose-volume histograms (DVHs) were used. The COV, a single number, is an indicator of treatment plan quality that takes into account actually achieved dose distributions for the PTV and organs at risk (OARs) after the plan optimization, relative to the initial constraints (Weiss et al 2007a , Suh et al 2008b . The smaller the COV, the better the treatment plan.
Results
Figures 3 and 4 show the DVHs and the COVs, respectively, of all ten individual phase plans with a deformable dose-summed 4D plan generated using the DMLC motion-tracking algorithm for each patient. The respiratory phase indices of 0 and 5 represent the end-inhale and end-exhale phases, respectively, with a respiratory cycle divided into ten phases of equal duration. The DVHs of the plans for individual phases of the 4D CT scan are, in general, similar to those of the reference phase plan, as well as to a deformable dose-summed 4D plan. The target coverage is similar from phase to phase, except for patients 1 and 11 (whose cases will be discussed later in this section), whereas the DVHs for OARs show variation. This variation is due to an intrinsic drawback of all tumor-tracking methods, which only track the tumor motion, not the motion of whole patient anatomy (Weiss et al 2007b) . That is, individual phase plans generated using the DMLC motion-tracking algorithm do not account for the phase-to-phase positional changes of OARs with respect to the tumor and/or to the BEV. In terms of overall plan quality (i.e., COV), most patients show similar plan qualities over individual phase plans (figure 4), except for patients 1 and 4 (whose cases will be discussed later in this section). Figure 4 also indicates that a COV of a deformable dose-summed 4D plan for each patient is, in general, similar to the average values over all individual phase plans per patient. There is variation in the COVs of individual phase plans for patients 1 and 4 (red and blue in figure 4 ). Figure 5 shows the DVHs of plans for phases 1, 2 and 4, which have worse plan quality than the other phase plans, compared with the reference phase plan, for patient 1. The isodose distributions for these phase plans are shown in figure 6 . Compared with the phase 5 plan, plans for phases 1, 2 and 4 have worse PTV coverage as seen in the transverse, coronal and sagittal planes. This is due to artifacts in the 4D CT image set of patient 1 and also tumor volume differences caused by the artifacts (worst for phase 1 in coronal and sagittal planes as in figure 6 ). The mean of relative tumor volume of each phase to phase 5 is 0.96, ranging from 0.79 to 1.07. Patient 4 shows not only phase-to-phase variation in plan quality but also a trend wherein the farther the respiratory phases are from phase 5, the worse the plan quality becomes (blue in figure 4 ). This is explained by the tumor volume variation during the respiratory cycle of patient 4. The mean of relative tumor volume of each phase to phase 5 is 0.92, ranging from 0.86 to 1.00. The significant variation in tumor volume causes inferior PTV coverage, especially for plans on the phases further away from phase 5, as shown in the isodose distributions in figure 7.
Whereas patients 1 and 4 show phase-to-phase variation in both the COVs and the DVHs, the COVs for patient 11 do not vary significantly from phase to phase (pink in figure 4 ) but the DVHs do vary (figure 3). Patient 11 actually shows the most discrepancy in the DVHs from phase to phase for both the PTV and OARs. The tumor of patient 11 shows the second largest volume, the second most motion and the most hysteresis during respiration (table 1) , which all cause phase-to-phase variation in treatment plans. The large tumor volume changes treatment plans from phase to phase due to stressing the optimization algorithm with more constraints to balance, and the motion and hysteresis change treatment plans due to changes in the geometric relation between the tumor and normal anatomy from phase to phase. Nonetheless, the DVHs of the deformable dose-summed 4D plan for patient 11 show the approximate average of the DVHs for individual phase plans (figure 3). The deformable dose-summed 4D plan for patient 1 is significantly worse than all individual phase plans (red in figure 4 ). The degraded 4D plan for patient 1 is also evident in the DVHs in figure 3 , primarily due to inferior PTV coverage. Large gradients of the deformation vector field, u, across the PTV deteriorate target coverage resulting in the deformable dosesummed 4D plan much worse than all individual phase plans discussed in the previous study (Suh et al 2008b) .
Discussion
A deliverable 4D IMRT treatment-planning method for DMLC tumor-tracking delivery that accounts for 1D tumor translation in the major axis only was previously developed (Suh et al 2008b) . It was a proof-of-principal study demonstrating that the deliverable 4D IMRT treatment-planning method is feasible. Though a 1D correction may be better than no correction, tumor motion is known to exhibit hysteresis and nonlinear behavior (Seppenwoolde et al 2002 , Suh et al 2008a . The current study modified and integrated a DMLC tumor-tracking algorithm in the deliverable 4D IMRT treatment-planning method. Thus, 3D translational tumor motion observed during the 4D CT planning scan is explicitly included in 4D treatment planning. Any changes in the motion observed during treatment delivery can be accounted for by using the algorithm during delivery. That is, the same algorithm is called for both planning and delivery of 4D IMRT treatment. This symmetry between planning and delivery for determining leaf sequences lends itself to clinical viability.
The 4D IMRT treatment plans created using the DMLC motion-tracking algorithm account for 3D tumor motion, and thus implicitly account for hysteresis and nonlinear motion. However, the rotations or deformations within a respiratory cycle and the differential motion of a tumor and normal tissues are not accounted for, as this algorithm is based on the assumptions that a tumor is rigid and does not undergo in-or out-plane rotations or deformations and the entire anatomy moves. The greater the respiratory tumor motion, the greater the improvement in a resultant treatment plan will be when the off-axis motion of tumor is taken into account. The 4D IMRT treatment-planning method developed in this study creates deformable dosesummed 4D plans with a quality level somewhere between the deliverable and the 3D optimal treatment plans in a previous study (Suh et al 2008b) .
Like currently available 3D radiotherapy treatment, some approximations are being made for 4D treatment planning and delivery. The 4D treatment planning is based on a 4D CT planning scan, which is usually taken long before actual delivery. Guckenberger et al showed that respiratory motion assessed by a 4D CT scan was reproducible during a time period corresponding to a high-dose stereotactic treatment, and concluded that for the majority of lung cancer patients studied, treatment planning based on a single 4D CT scan appeared to be reliable (Guckenberger et al 2007) . On the other hand, Minn et al showed that a 4D CT planning scan cannot accurately predict pancreatic tumor motion during actual delivery for radiosurgery (Minn et al) . Thus, it is not always true that the 4D CT image set represents the location and motion of patient's anatomy during treatment delivery; rather, a patient's motion pattern would most likely change between imaging and delivery. Nevertheless, the patient's anatomic motion during imaging is at this time the best possible estimation for what it will be during delivery. As there is no further information on patient's anatomy beyond one single 4D CT planning scan, as is often the case in clinic, this estimation is necessary. If 4D cone-beam CT (Sonke et al 2005 , Li et al 2006a , 2006b or 4D magnetic resonance imaging (Remmert et al 2007 , von Siebenthal et al 2007 is available, the most recent information on the patient's anatomic location is used. Even when the updated information is available, the assumption to correlate the anatomic location during imaging to that during delivery is still required. With a 4D treatment plan, 4D treatment delivery assumes that during delivery there exists real-time information on both 3D target location and respiratory phase, which is from either measurement or estimation.
The 4D IMRT treatment-planning method using the DMLC motion-tracking algorithm was applied to 12 lung cancer patient 4D CT image sets. As for individual phase plans, phase-to-phase variation was generally smaller than patient-to-patient variation, indicating that individual phase plans were similar to one another for each patient. The deformable dosesummed 4D plan was similar to the average over individual phase plans, except for patient 1. The DVHs and dose distribution of an IMRT plan for every phase of the 4D CT scan were similar to those of the reference phase plan, as well as the deformable dose-summed 4D plan, for each patient. This indicates that this method is dosimetrically robust to the variation of fractional time spent in respiratory phases on a given 4D CT scan. It also reveals that this method would result in the dose distribution close to the planned dose distribution, even when a patient spends more time on one phase (e.g., the end-exhale phase) than other phases during treatment delivery.
Similar phase-to-phase DVHs are desirable when it comes to target coverage, which in addition to PTV margin reduction is a primary goal of tumor-tracking methods. However, tumor-tracking techniques do not track the surrounding normal anatomy that deforms and/or moves relative to the tumor and/or in or out of BEV. Thus, the DVHs for OARs of some of the plans generated by the DMLC motion-tracking algorithm show more variation from phase to phase than those for the PTV.
In 2 patients out of 12, this method was affected by the changes in tumor volume from phase to phase. These tumor volume changes can be attributed to either artifacts in the 4D CT image set as in patient 1 or tumor volume variation throughout the respiratory phases as in patient 4. For patient 1, severe artifacts, which possibly happen in real clinical cases, caused phase-to-phase variation in individual phase plans. In one case, high vector field variation from a deformable registration affected this method (patient 1). This was discussed in detail in the previous study (Suh et al 2008b) .
For each beam in the IMRT treatment plans, the collimator was rotated to align the MLC leaf travel direction parallel to the major axis of tumor motion, which was determined as seen in a given BEV. This makes the tumor motion in the other two directions, the motion perpendicular to the major axis and along the beam direction, relatively small. The tumor motion perpendicular to the MLC leaf travel direction and along the beam direction is 0.2 and 0.4 cm, respectively, at the most (table 1) . Consequently, the collimator rotation minimizes the decrease in delivery efficiency for the motion perpendicular to the MLC leaf travel direction as much as possible.
Conclusions
A 4D IMRT treatment-planning method that accounts for 3D tumor motion was developed and investigated using 12 lung cancer patient 4D CT image sets. A DMLC motion-tracking algorithm previously developed for real-time tumor tracking was modified to allow 4D treatment planning and delivery using the same underlying algorithm. Using this method, the DVHs and isodose distributions of an IMRT plan for every phase of the 4D CT scan were, in general, similar to those of the reference phase plan, as well as the deformable dosesummed 4D plan. This indicates that the method is dosimetrically robust to the variation of fractional time spent in respiratory phases on a given 4D CT scan. This method is affected by 4D CT artifacts and high vector field variation from a deformable registration in one case. Creating 4D IMRT treatment plans using the DMLC motion-tracking algorithm explicitly accounts for 3D tumor motion and thus hysteresis and nonlinear motion, and is deliverable on a linear accelerator. This method integrates deliverable treatment planning with DMLC tumor-tracking delivery, and has a clear path to clinical implementation.
